Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Hepatology. 2015 Mar 23;62(2):635–643. doi: 10.1002/hep.27744

Table 1.

Potency of human PPAR agonists, modified from Wilson TM et al. (16).

Ligand Human receptor EC50 (μM)
PPARα PPARβ/δ PPARγ
Wy-14,643 5 35 60
Clofibratea 55 IA at 100 ~500
Fenofibrate 30 IA at 100 300
Bezafibrate 50 20 60
a

data is for the active metabolite, IA = inactive.